FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia

Jen, E. Y., Ko, C.-W., Lee, J. E., Del Valle, P. L., Aydanian, A., Jewell, C., Norsworthy, K. J., Przepiorka, D., Nie, L., Liu, J., Sheth, C. M., Shapiro, M., Farrell, A. T., Pazdur, R.
The American Association for Cancer Research (AACR)
Published 2018